1 2 Streptococcus agalactiae (group B Streptococcus; GBS) is a cause of severe infections, 3 particularly during the newborn period. While methods exist for generating chromosomal 4 mutations in GBS, they are cumbersome and inefficient and present significant challenges if the 5 goal is to study subtle mutations such as single base pair polymorphisms. To address this 6 problem, we have developed an efficient and flexible GBS mutagenesis protocol based on 7 sucrose counterselection against levansucrase (SacB) expressed from a temperature-selective 8 shuttle vector. GBS containing the SacB expression cassette demonstrate lethal sensitivity to 9 supplemental sucrose whether the plasmid DNA is replicating outside of the chromosome or 10 has been integrated during a crossover event. Transmission electron microscopy shows that 11 SacB-mediated lethal sucrose sensitivity results from accumulation of inclusion bodies that 12 eventually lead to complete degradation of normal cellular architecture and subsequent lysis. 13
Importance 24 25
The ability to generate chromosomal mutations is fundamental to microbiology. Historically, 26 however, GBS pathogenesis research has been made challenging by the relative genetic 27 intractability of the organism. Generating a single knockout in GBS using traditional techniques 28 can take many months, with highly variable success rates. Furthermore, traditional methods do 29 not offer a straightforward way to generate single base pair polymorphisms or other subtle 30 changes, especially to noncoding regions of the chromosome. We have developed a new 31 sucrose counterselection-based method that permits rapid, efficient, and flexible GBS 32 mutagenesis. Our technique requires no additional equipment beyond what is needed for 33 traditional approaches. We believe that it will catalyze rapid advances in GBS genetics research 34 by significantly easing the path to generating mutants. 35 Introduction 37
38 Streptococcus agalactiae (group B Streptococcus; GBS) is the most common cause of neonatal 39 sepsis and meningitis (1-3). It can also cause serious infections in adults (4, 5) and in several 40 animal species, including fish, which can be a source of zoonotic transmission (6-9). 41 42 GBS is not naturally competent under laboratory conditions (10) and exhibits low rates of 43 spontaneous genetic recombination (11) . Genetic studies of GBS have mostly relied on 44 generation of allelic exchange knockouts using mutagenesis cassettes cloned into a 45 temperature-sensitive shuttle vector (12) (13) (14) . The mutagenesis cassette typically consists of an 46 antibiotic resistance marker with upstream and downstream homology arms matching the 47 chromosomal regions adjacent to the target gene. A second antibiotic resistance marker on the 48 plasmid, outside of the mutagenesis cassette, confers dual resistance to transformed cells. 49 50 After electroporation and transformation of competent GBS with the mutagenesis vector, 51 transformed clones are initially grown at a permissive temperature, which allows 52 extrachromosomal replication of the plasmid. A subsequent shift to a higher, non-permissive 53 temperature selects against extrachromosomal plasmid replication, leaving only cells where a 54 crossover event at one of the homology arms has resulted in plasmid integration into the 55 chromosome. 56 57 In order to achieve allelic exchange, a second crossover event must then occur at the other 58 homology arm, followed by plasmid expulsion from the cell. Successful completion of these 59 steps is detected by screening individual colonies for a specific antibiotic resistance phenotype: 60 retained antibiotic resistance from the mutagenesis cassette marker with sensitivity to the 61 second antibiotic due to loss of the plasmid during growth at the non-permissive temperature 62 (12) . 63 64 Without effective counterselection against the plasmid, however, detection of the second 65 crossover event-a stochastic and often rare occurrence-is inefficient. Particularly if the 66 desired mutant has a fitness disadvantage compared to wild type, identification of an allelic 67 exchange mutant may require manual screening of hundreds or thousands of individual 68 colonies (15) . 69 70 Furthermore, the existing approach limits the types of mutants that can be generated. Since the 71 final screen depends on persistence of one antibiotic resistance phenotype with loss of a 72 second, mutants produced using traditional techniques must include an antibiotic resistance 73 marker on the chromosome. Small-scale and unmarked alterations, such as single nucleotide 74 polymorphisms (SNP) or subtle mutations to noncoding regions, are very difficult to obtain. 75 76 Levansucrase (sucrose: 2,6-b-D-fructan 2,6-b-D-fructosyltransferase) is an enzyme present in 77 multiple bacterial species and has been extensively studied in Bacillus subtilis (16-21). Encoded 78 by the sacB gene, secreted B. subtilis levansucrase polymerizes sucrose into the branched 79 fructan polymer known as levan (16, 19) . While the exact function of levansucrase in B. subtilis 80 is unknown, the levan that it generates is believed to serve a structural or nutrient role for the 81 cell (17). 82
83
In other bacterial species, expression of B. subtilis sacB confers lethal sensitivity to sucrose (22, 84 23). The mechanism of sucrose toxicity is believed to be from either intracellular or extracellular 85 accumulation of levan, with resultant disruption of normal cellular processes. Sucrose 86 sensitivity from sacB expression has been used as counterselection in conjunction with plasmid-87 based mutagenesis systems to isolate mutants in several bacterial species (22, 23). To date, 88 however, the technique has not been described in GBS. 89 90 Here we report development and validation of a flexible and efficient counterselection system 91 to make targeted mutations in GBS using a sacB-containing, temperature sensitive, broad host 92 range plasmid. A schematic of this new system is presented in Figure 1 . We show that the 93 system can be used to generate marked and unmarked mutations in multiple GBS strains. Plasmid pMBsacB is derived from pHY304, a widely used mutagenesis shuttle vector with the 103 temperature-sensitive broad host range origin of replication from pWV01 (12, 24). 104
105
The B. subtilis sacB coding sequence, complete with signal peptide sequence, was amplified 106 from strain 168 purified genomic DNA and cloned into plasmid pOri23, which placed the sacB 107 gene downstream of the p23 promoter. This plasmid is designated pSacB23, and was used in 108 initial experiments to test sacB functionality in GBS (see next section). 109
We subsequently generated pMBsacB by amplifying the p23 promoter and sacB coding 111 sequence as a single expression cassette then subcloning it into pHY304. Figure 2 shows the 112 steps involved in developing pMBsacB. 113 114 GBS transformed with sacB-bearing plasmids show lethal sucrose sensitivity 115 116 Before transforming GBS with sacB-bearing plasmids pSacB23 and pMBsacB, we developed an 117 electroporation protocol that did not include the use of sucrose, which is typically used as an 118 osmoprotectant to prevent bacterial death during transformation (24, 25). We had observed 119 very low rates of successful transformation during early trials with sucrose osmoprotection 120 (data not shown), presumably due to sucrose-mediated toxicity. 121
122
We initially tried replacing sucrose with maltose, a structurally related disaccharide that we 123 hoped would not be lethal to cells transformed with sacB plasmids. However, there was no 124 significant increase in transformation efficiency with maltose osmoprotection (data not shown), 125 which we attributed to sacB nonspecific reactivity with maltose, likely generating 126 maltosylfructose (26, 27) . 127 128 Our transformation efficiency returned to expected levels (10 -4 -10 -5 per µg plasmid DNA for GBS 129 strain CNCTC 10/84) with replacement of sucrose osmoprotectant with 25% (mass:mass) 130 polyethylene-glycol (average MW 6000 daltons; PEG-6000), which we dissolved in rich 131 transformation media for competent cell outgrowth and in the wash solution in which we store 132 and electroporate competent GBS. 133 134 GBS strain 10/84 transformed with pSacB23 or pMBsacB showed significant growth defects on 135 solid media with supplemental 0.75 M sucrose ( Figure 3A) . We also tested the sensitivity of 136 planktonic 10/84:pMBsacB to sucrose added to liquid media, and found significant growth 137 impairment. Planktonic and solid media exposure could also be combined ( Figure 3B) . 10/84 138 transformed with pHY304, by contrast, did not demonstrate significant sucrose sensitivity. 139
140
In order to directly visualize the phenotypic effect of sucrose exposure on GBS expressing SacB, 141
we performed transmission electron microscopy on 10/84 transformed with pMBsacB or 142 pHY304 and exposed to sucrose or control conditions. As shown in Figure 4A To test whether sucrose counterselection could be used in GBS to produce allelic exchange 153 mutants, we applied our system to deleting a gene that we and others had experience knocking 154 out: the sortase gene srtA (28). This provided a benchmark against which efficiency of 155 counterselection-assisted mutagenesis could be measured. passaged three times at 37 °C with chloramphenicol selection. Serial dilutions were then plated 173 on chloramphenicol-containing solid media with or without erythromycin selection. While the 174 overall CFU concentration did not differ significantly between conditions-as indicated by equal 175 growth on non-selective media-there was a dramatic difference between pMBsacB grown in 176 the presence of sucrose and the other three outgrowth conditions. Exposure of the pMBsacB 177 single-cross strain to sucrose eliminated virtually all erythromycin-resistant survival, suggesting 178 successful counterselection (Figure 5A-B) . PCR of the cat gene generated the expected 660-bp 179 gel electrophoresis bands when genomic DNA from colonies that survived counterselection was 180 used as template, but not wild type GBS DNA (Figure 5C ). Sanger sequencing of DNA amplified 181 using PCR primers that bind outside of the dSrtA homology arms confirmed that the srtA gene pigmented phenotype expected of the knockout. If not exposed to sucrose, the single-cross 213 intermediate retained erythromycin resistance and the colonies were uniformly nonpigmented, 214 reflecting the fact that the population consisted almost entirely of unchanged, single-cross 215
CFUs. 216
In the 10/84 experiment, we selected four non-pigmented colonies from the non-selective plate 218 on which the sucrose-exposed culture had been grown. These were used for genomic DNA 219 purification, followed by amplification of the cylE coding sequence and Sanger sequencing. One 220 of the four had the correct barcoded sequence, whereas the other three did not properly 221 amplify during PCR, suggesting that the plasmid auto-excised in a manner that left a partial 222 sequence deletion (Figure 6C) . 223
224
In the case of A909, 20 out of 24 non-pigmented isolates properly amplified by PCR. We 225 sequenced ten of these, nine of which had the expected barcoded premature stop codon 226 ( Figure 6C ). Both 10/84 and A909 cylE knockout strains generated using pMBsacB:dCylE showed 227 the anticipated non-pigmented, non-hemolytic phenotype (Figure 6D) . 228 229 Unintended deletions during the final plasmid-excision is a phenomenon that we have 230 subsequently observed in other mutagenesis experiments, suggesting that all mutants 231 generated with pMBsacB must be confirmed by some combination of PCR and sequencing to 232 ensure the desired genotype. 233 234 Discussion 235
Reliable methods for creating specific mutations are central to microbiological discovery. 236
Existing methods for doing so in GBS have been limited in multiple respects. Without 237 counterselection, the final screening step for plasmid auto-excision and curing is unreliable and 238 inefficient, since it depends on random identification of a low-probability biological event. 239 Furthermore, most current methods rely on replacement of a coding sequence with an 240 antibiotic resistance marker; this does not support rapid generation of small changes to the 241 chromosome, such as individual SNPs. An earlier counterselection-based approach to GBS 242 mutagenesis was limited by the fact that it required an already mutated background strain, 243 which is not ideal for pathogenesis work (15). Together, these barriers make isolation of 244 complex mutants with multiple, subtle chromosomal changes infeasible. 245
246
Our sacB-mediated counterselection system overcomes these limitations. The method is simple 247 and does not require any additional equipment or experience beyond what is required for 248 traditional approaches. 249 250 We validated our system by generating two knockouts: one (srtA) involved allelic exchange with 251 a chloramphenicol resistance marker, while the other (cylE) demonstrated the ability of our 252 technique to produce small chromosomal changes at the single nucleotide level. In order to 253 confirm that the system works in multiple GBS strains from different serotypes (which can show 254 phenotypic variability under the same growth conditions), we generated the same cylE 255 mutation in A909 (serotype Ia) and 10/84 (serotype V). We noted that A909 grew less robustly 256 on 0.75 M sucrose than 10/84; so for the A909 cylE mutation, we used 0.5 M sucrose 257 counterselection. When using this system in different strains, it is important to optimize the 258 counterselection conditions prior to starting a new mutation. 259
As Figure 5 shows, the srtA knockout can be generated at reasonable rates even without 261 counterselection. There was considerable variability from one experimental replicate to the 262 next, but the mean recovery rate of knockouts in the sucrose-negative conditions was 29-57%, 263 regardless of whether the mutagenesis plasmid was pHY304 or pMBsacB. In contrast, the mean 264 recovery rate in the pMBsacB sucrose-positive condition was 99%, with low variability. 265
266
In the case of low-fitness mutations, however, rates of recovery without counterselection can 267 be much lower (32). The last step in the mutagenesis workflow-auto-excision and curing of the 268 plasmid-essentially establishes a competition assay between the single-cross strain and the 269 intended mutant (12). If the mutant has a survival defect, the odds of randomly selecting a 270 mutant colony from among the single-cross population is very low. By shrinking the single-cross 271 background, the pMBsacB counterselection system increases the odds of isolating the desired 272 mutant. Particularly when the goal is mutation of high-fitness genes, we have found that it is Genomic DNA from GBS and B. subtilis was isolated using the Applied Biosystems MagMAX 320 CORE kit (product number A32700) with a KingFisher magnetic bead processing system 321 according to manufacturer instructions, with the following minor modifications. Overnight 322 liquid culture volumes were 1-10 mL. After pelleting by centrifugation at 3200 x g, the bacteria 323 were lysed in a solution containing 100 µL manufacturer-supplied proteinase K and PK buffer, 324 50 µL lysozyme (100 mg/mL in water), and 5 µL mutanolysin (10 kU in 2 mL 0.1 M potassium 325 phosphate buffer pH 6.2). Lysis was performed at 37 °C for 30 minutes, then 55 °C for 30 326 minutes, followed by a 2-minute centrifugation at 3200 x g. The rest of the extraction followed 327 manufacturer instructions, using the MagMAX CORE Flex KingFisher protocol file. Single 10/84 or A909 colonies from TS agar plates were used to seed 5 mL M17 (BD Difco 346 218561) + 0.5% glucose liquid cultures, which were grown at 37 °C to stationary phase. 500 µL 347 from these cultures were then used to seed filter sterilized 50 mL M17 + 0.5% glucose, 2.5% 348 (A909) or 0.6% (10/84) glycine, and 25% (mass:mass) PEG-6000. 349
350
Following overnight growth at 37 °C, this culture was diluted in pre-warmed 130 mL of the 351 same media and allowed to grow for 1 hr. The entire volume was pelleted at 3200 x g, then 352
washed twice in ice cold 25% PEG-6000 + 10% glycerol. Following these washes, the samples 353 were resuspended in 1 mL of wash solution and either used immediately for transformation or 354 stored in aliquots at -80 °C. sucrose, grown to log phase, then exposed to sucrose supplementation (or control outgrowth 368 with only sterile water added to the broth) for two hours, at which time the cultures were 369 diluted and plated on appropriate solid media for CFU quantification after 1-2 days of growth. 370 371 Transmission electron microscopy 372 373 10/84 transformed with pMBsacB or pHY304 was grown to mid-log phase in selective broth. 374
That culture was used to seed a new culture with or without supplemental sucrose. After 375 outgrowth to early-mid log phase, the bacteria were fixed with 2.5% glutaraldehyde and 2% 376 paraformaldehyde and washed with cacodylate buffer (50 mM, pH 7.2), then post fixed with 2% 377 osmium tetroxide. Bacteria were embedded in 2% agar, then cut and stained in the dark with After transformation of GBS, using the method described above, with pMBsacB (or pHY304 412 control) bearing a mutagenesis cassette (dSrtA or dCylE), successful transformants were grown 413 in TS broth with appropriate antibiotic selection (erythromycin with or without 414 chloramphenicol) at 28 °C. Sucrose sensitivity of the transformants was confirmed by plating 415 serial dilutions on TS agar with 0.5 M (for A909) or 0.75 M (for 10/84) sucrose and appropriate 416 antibiotic selection at 28 °C. 417
418
To generate single-cross intermediates, transformants were serially passaged three times at 28 419 °C with erythromycin selection. The third passage was then used to seed another culture at 37 420 °C with erythromycin selection, which was grown overnight. Serial dilutions of the final culture 421 were plated on TS agar with erythromycin at 37 °C. Individual colonies were grown and tested 422 for sucrose sensitivity. Genomic DNA was also extracted and tested by PCR for proper vector 423 insertion using either cylE_farout_F or srtA_farout_F, which match chromosomal sites outside 424 of the homology arms, and pMBsacB_MCS_F, which binds pMBsacB and pHY304 upstream of 425 the cloning sites used in this study (data not shown). 426 427 Single-cross intermediate strains with the correct sucrose sensitivity phenotype and PCR-428 confirmed genotype were then grown in TS broth without antibiotics at 28 °C and passaged 429 three times in order to enrich for spontaneous double-cross events. To counterselect against 430 pMBsacB, the third passage was used to seed TS broth with sucrose at 37 °C. In srtA knockout 431 experiments, chloramphenicol was added to the sucrose-containing broth. The sucrose culture 432 was passaged three times at 37 °C, and then serial dilutions were plated on TS agar with or 433 without chloramphenicol. Simultaneous plating on erythromycin-containing TS agar (with or 434 without chloramphenicol) was used to quantify the effectiveness of counterselection against 435 pMBsacB. 436 437 Knockout candidates from the non-erythromycin plate were confirmed to be erythromycin 438 sensitive by patching to a new plate. Genomic DNA extraction followed by PCR and Sanger 439 sequencing confirmed plasmid excision and the correct knockout DNA sequence. For the srtA 440 knockout, the region was amplified using primers srtA_farout_F/R and these amplicons were 441 sequenced using srtA_farout_F and cat_F primers. For the cylE knockout, the region was 442 amplified using cylE_farout_F/R and the barcoded mutation was confirmed by sequencing with 443 the dCylE_conf_F primer. candidates, but not from wild type (WT) or template-negative (Neg) controls (C). Sanger sequences of the srtA region amplified using primers outside of the mutagenesis cassette were combined to generate a consensus sequence, which was aligned to the expected knockout template. Erm=erythromycin, Cm=chloramphenicol, suc=sucrose. 
